STAT June 24, 2024
Lizzy Lawrence

When a new medical device hits the market, there’s typically still some uncertainty about whether it works.

Device makers generally do not have to submit as much, or as rigorous, clinical data to the Food and Drug Administration as their biotech counterparts. Once FDA regulators decide a device is safe and effective, companies and researchers then attempt to track how the device performs in the real world.

But tracking devices is tricky. The FDA...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Medical Devices, Provider
Two Key Takeaways From The HFMA Conference
The Stanford AI Index 2024: 5 Takeaways For Business
Humanizing Data: 3 Steps For Transforming Health
Changing hospital eligibility for the 340B drug program | Bills and Laws
No One Wins in a Medical Student Research Arms Race

Share This Article